Use of carbapenems and glycopepdides is significant risk for multidrug resistant Acinetobacter baumannii infections | Zendy

Salih Hoşoğlu | Zendy; Eyüp Arslan | Zendy; Emel Aslan | Zendy; Özcan Deveci | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of carbapenems and glycopepdides is significant risk for multidrug resistant Acinetobacter baumannii infections

Author(s) -

Salih Hoşoğlu,

Eyüp Arslan,

Emel Aslan,

Özcan Deveci

Publication year - 2018

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.8081

Subject(s) - acinetobacter baumannii , medicine , antibiotics , multiple drug resistance , univariate analysis , risk factor , multivariate analysis , intensive care medicine , microbiology and biotechnology , biology , genetics , bacteria , pseudomonas aeruginosa

Multi-drug resistant Acinetobacter baumannii (MDR-Ab) infections are an important healthcare problem globally. The aim of this study was to evaluate risk factors associated with MDR-Ab infections in hospitalized patients in Turkey.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research